Bentebibel, Salah-Eddine
Diab, Adi
Article History
Accepted: 30 March 2021
First Online: 18 May 2021
Declarations
:
: Salah-Eddine Bentebibel declares that he has no conflict of interest. Adi Diab has received a commercial research grant from Nektar Therapeutics and declares he is a consultant/advisory board member for Nektar Therapeutics.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).